Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Influence of Pelacarsen on Arterial Wall Properties and Risk Factors in Patients After Myocardial Infarction With High Lp(a) Values

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT04993664
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:21.554360+00:00
Published At
2022-01-03T00:00:00+00:00
Record Updated At
2022-01-03
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Coronary Syndrome", "Lipoproteinemia", "Inflammation", "Genetic Polymorphisms"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-01-03"
protocolSection.identificationModule.nctId
"NCT04993664"
protocolSection.identificationModule.officialTitle
"Influence of Pelacarsen on Arterial Wall Properties and Risk Factors in Patients After Myocardial Infarction With High Lp(a) Values"
protocolSection.statusModule.overallStatus
"WITHDRAWN"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Acute Coronary Syndrome (protocolSection.conditionsModule.conditions)
  • Lipoproteinemia (protocolSection.conditionsModule.conditions)
  • Inflammation (protocolSection.conditionsModule.conditions)
  • Genetic Polymorphisms (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.